# Biomarin Pharmaceutical Inc: Form 8-K, filed Oct 27, 2025

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2025-10-27
- Accepted by EDGAR: Oct 27, 2025, 16:08 ET
- Period: 2025-10-27
- Accession: 0001048477-25-000104
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000104/bmrn-20251027.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000104847725000104/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000104847725000104/bmrn-20251027.htm

Filed Oct 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001048477-25-000104. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.